MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
CNTB — Connect Biopharma Holdings Limited Ordinary Shares
NasdaqConnect Biopharma Holdings Limited Ordinary Shares
$0.93
-0.05(-5.38%)
- O
- 0.98
- H
- 1.08
- L
- 0.89
- V
- 4.13M
⏱️ End-of-day dataAs of Oct 2, 2026
Chart
About CNTB
Connect Biopharma Holdings Ltd is a clinical-stage biopharmaceutical company dedicated to transforming care for asthma and chronic obstructive pulmonary disease (COPD). The company is advancing rademikibart, a next-generation antibody designed to target interleukin-4-receptor alpha. It is currently conducting clinical studies of rademikibart for the treatment of acute exacerbations of asthma and COPD. The company operates in one operating segment: treatment of respiratory diseases.
IndustryPHARMACEUTICAL PREPARATIONS
SectorNot available
IPO DateSep 3, 2025
Employees64
Stock ExchangeNasdaq
Ticker SymbolCNTB
Key Financial Statistics
| Market Cap | $68.01M |
| P/E Ratio | N/A |
| Dividend Yield | None |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $0.89 - $3.82 |
| 52-Week Avg Volume | 1.16M |
| VWAP | $0.96 |
| Transactions | 12,927 |
| Total Recorded Bars | 1,393 days |